CathepsinDL: Deep Learning-Driven Model for Cathepsin Inhibitor Screening and Drug Target Identification

Cathepsins are lysosomal proteases which are crucial for protein breakdown, bone remodelling and antigen processing and whose dysregulation leads to diseases like cancer, osteoporosis and neurodegenerative disorders, making them an important drug target. This study introduces a 1D Convolutional Neural Network-based classification model to enhance screening for potential cathepsin inhibitors, leading to more efficient selection of potential targets for experimental validation. The dataset was gathered from BindingDB and ChEMBL with the target Cathepsin B, S, D and K and the respective half-maximal inhibitory concentration (IC<sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>) values for their inhibitors, which were categorized into four classes—potent, active, intermediate, and inactive—based on the ranges of IC<sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub> values. The inhibitor ligands were collected in the Simplified Molecular Input Line Entry System (SMILES) notation and were converted to molecular descriptors using the RDKit library. Due to the large number of features, feature selection techniques such as Recursive Feature Elimination (RFE), variance thresholding, and correlation analysis were employed to refine and reduce the initial molecular descriptor set. Data augmentation techniques like Synthetic Minority Over-sampling Technique (SMOTE) were applied to address the issue of class imbalance. The proposed model achieved high classification accuracies, with Cathepsin B at 97.67%±0.54%, Cathepsin S at 90.69%±0.57%, Cathepsin D at 97.27%±0.23%, and Cathepsin K at 92.03%±1.07%, highlighting the effectiveness of feature selection and deep learning in ligand classification. This approach enhances the identification of potential drug targets for in vitro and in vivo testing, making the process more cost-effective and time-efficient.

Authors

Institutions

Publication Details

Journal
IEEE Access
Published
2025-01-01
DOI
https://doi.org/10.1109/access.2025.3617246
Primary Topic
Machine Learning in Bioinformatics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CathepsinDL: Deep Learning-Driven Model for Cathepsin Inhibitor Screening and Drug Target Identification

Tapan Kumar Sahoo, Kaushik Mishra, Chandra Mohan Sah, Santosh Kumar Majhi et al.
IEEE Access
Machine Learning in Bioinformatics
article

CathepsinDL: Deep Learning-Driven Model for Cathepsin Inhibitor Screening and Drug Target Identification

Tapan Kumar Sahoo, Kaushik Mishra, Chandra Mohan Sah, Santosh Kumar Majhi, Mohammed Junaid Anwar Qader
article en

Abstract

Cathepsins are lysosomal proteases which are crucial for protein breakdown, bone remodelling and antigen processing and whose dysregulation leads to diseases like cancer, osteoporosis and neurodegenerative disorders, making them an important drug target. This study introduces a 1D Convolutional Neural Network-based classification model to enhance screening for potential cathepsin inhibitors, leading to more efficient selection of potential targets for experimental validation. The dataset was gathered from BindingDB and ChEMBL with the target Cathepsin B, S, D and K and the respective half-maximal inhibitory concentration (IC<sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>) values for their inhibitors, which were categorized into four classes—potent, active, intermediate, and inactive—based on the ranges of IC<sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub> values. The inhibitor ligands were collected in the Simplified Molecular Input Line Entry System (SMILES) notation and were converted to molecular descriptors using the RDKit library. Due to the large number of features, feature selection techniques such as Recursive Feature Elimination (RFE), variance thresholding, and correlation analysis were employed to refine and reduce the initial molecular descriptor set. Data augmentation techniques like Synthetic Minority Over-sampling Technique (SMOTE) were applied to address the issue of class imbalance. The proposed model achieved high classification accuracies, with Cathepsin B at 97.67%±0.54%, Cathepsin S at 90.69%±0.57%, Cathepsin D at 97.27%±0.23%, and Cathepsin K at 92.03%±1.07%, highlighting the effectiveness of feature selection and deep learning in ligand classification. This approach enhances the identification of potential drug targets for in vitro and in vivo testing, making the process more cost-effective and time-efficient.

IEEE AccessVol. 13
National Institute of Technology Warangal (IN), Manipal Academy of Higher Education (IN), Guru Ghasidas Vishwavidyalaya (IN)
Openalex Percentile: Top 75%
Machine Learning in Bioinformatics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.